Navigation Links
Memory Loss Linked to Cognitive Disorders

A new study has developed the first images of the physical changes in brain cells thought to underlie memory thus linking memory loss to cognitive disorders.

Earlier studies have established that a physiological effect known as long-term potentiation (LTP) encodes everyday forms of memory.

In neuroscience, LTP is an increase in the strength of a chemical synapse that lasts from minutes to several days. It is widely considered one of the major mechanisms by which memories are formed and stored in the brain.

The study was conducted by a team of researchers led by Christine M. Gall and Gary Lynch at the University of California, Irvine.

As part of the study, researchers collected brain tissues from rats and mice, which was kept alive in specially constructed equipment and induced LTP by stimulating synapses with a rhythm known to be critical to memory formation.

The brain slices were then sectioned and stained with one antibody that attaches to activated proteins involved with LTP and a second one that labels synapses. Newly developed microscopic methods were used to visualize and measure synapses that had both antibodies attached.

Researchers found with the images that the size and shape of synapses were changed by LTP.

It was shown how LTP deficiencies accompany the memory loss seen during the early stages of Huntingtons disease, an incurable neurodegenerative disease characterized by disturbances to memory and learning.

The way is now open to mapping where in the brain memories are laid down. Seeing memory-related physical changes to synapses means that we can at last use mouse models to test if the effects of retardation, aging and various cognitive disorders involve a specific, long-suspected defect in the connections between cortical neurons, Lynch said.

Scientists also found that LTP structures encoding memory were defective in mouse mod els of Huntingtons disease. They discovered that these synaptic defects could be fully reversed through treatment with a brain growth factor released at synapses.

Ampakines, a new class of drugs developed by researchers that is currently in clinical development for Alzheimers disease and ADHD, increase the levels of this growth factor and potentially emerge as a therapy for the cognitive problems associated with Huntingtons.

The findings of the study were published in the May issue of the Journal of Neuroscience.


'"/>




Related medicine news :

1. Memory problem? solve a crossword
2. Deep Sleep Doesnt Increase Memory
3. For a Better Memory
4. Memory loss associated with microbes
5. Memory loss always goes hand with Depression
6. Memory deprivation after operations
7. Sage Improves Memory
8. Memory said to automatically improve with age
9. Enzyme Associated with Memory
10. Enzyme Associated With Memory
11. New Drug Combination Found To Improve Memory in Alzheimer’s Patient
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... IL (PRWEB) , ... October 13, 2017 , ... ... which established the certification process to promote standards of excellence for the field ... Symposium, scheduled for March 22 – 25, 2018 in Orlando, Florida at the ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Many families ... However, many long-term care insurance companies have a waiver for care if the client ... elimination period, when the family pays for care, is often waived, so the benefits ...
(Date:10/13/2017)... ... October 13, 2017 , ... Talented host, actor Rob Lowe, ... in a new episode of "Success Files," which is an award-winning educational program ... investigates each subject in-depth with passion and integrity. , Sciatica occurs when the ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent ... sleep apnea using cutting-edge Oventus O2Vent technology. As many as 18 million ... by frequent cessation in breathing. Oral appliances can offer significant relief to about ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... a leader in post-acute health care, have expanded their existing home health joint ... Health. , AccentCare has been operating a joint venture home health company with ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)...  Eli Lilly and Company (NYSE: LLY ... quarter of 2017 on Tuesday, October 24, 2017. Lilly ... with the investment community and media to further detail ... will begin at 9 a.m. Eastern time. Investors, media ... of the conference call through a link that will ...
(Date:10/2/2017)... Labs announces the European launch of their new low volume, high ... in Cambridge, U.K on October 4th. The ... with unprecedented speed and sensitivity while using far less sample volume ... ... ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, Inc. ... earnings conference call and webcast on Friday, November 3, ... (EDT) and ending at approximately 8:30 a.m. (CDT) / ... the company,s 2017 financial performance and guidance for 2018, ... initiatives to enhance operational performance, and long-range financial outlook ...
Breaking Medicine Technology: